Nutraveris

Category 'CONVICTIONS'

Tuesday, October 25, 2016
Category : News, CONVICTIONS, INGREDIENTS, INNOVATION, food safety | Author : experts | Comment : No Comments
Tags:

succes

 

As the leading European consultancy in nutrition and health, Nutraveris has worked with the Korean company Naturalendo Tech Co., Ltd in order to obtain the authorization to put EstroG-100® on the European market. Estro-G100® is a hot-water extract of a mixture of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz and Angelica gigas Nakai), already used in Korea, USA and Canada for the management of menopausal symptoms. After an initial evaluation from Ireland that didn’t raise any safety concern, EFSA was mandated by the European Commission at the request of some Member States for a scientific evaluation.

EFSA has now recognized that EstroG-100® is safe for the use of food supplements intended for post-menopausal women. The application provided a full characterization of the three botanicals as of the combination. Moreover, the safety of EstroG-100 was substantiated by in vitro and in vivo studies conducted either with EstroG-100® or single herbs. The applicant provided also two human clinical trials highlighting the safe use of EstroG-100® in post-menopausal women.

This success demonstrates once again the strengths of Nutraveris, either in the preparation and submission of Novel Food applications, and in its follow-up during Member States and EFSA evaluations.

Do not hesitate to contact our team to obtain authorization for your ingredients.

Tuesday, June 26, 2012
Category : News, CLAIMS, CONVICTIONS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags: , ,

This review presents the influence of phytosterols on the development of atherosclerosis. The plasma cholesterol-reducing effect of phytosterols has been recognized in several studies, but the usefulness of phytosterols in preventing coronary heart disease remains controversial. Phytosterols may also induce inflammation and reduce cholesterol efflux from macrophages, conditions that are directly implicated in the development of atherosclerosis.

Reported to the major problem in health and nutrition claims, one might question the benefit of lowering cholesterol by phytosterols which would lead to atherosclerosis, and then why these ingredients gained authorized claims while others, such as plants, are systematically denigrated by EFSA!

Reference: Lottenberg AM, Bombo RP, Ilha A, Nunes VS, Nakandakare ER, Quintão EC. Do clinical and experimental investigations support an antiatherogenic role for dietary phytosterols/stanols? IUBMB Life. 2012 Apr;64(4):296-306.

Tuesday, June 5, 2012
Category : News, CONVICTIONS | Author : experts | Comment : No Comments
Tags: ,

After the publication of the new EFSA guidance related to bone, joints, skin and oral health (cf. article of NutraverisPost on this topic), the European experts in health and nutrition have been consulted by Nutraingredients on the contribution of this document. For Nutraveris, even if the main part of the guidance brings only few interesting information, it allows the recruitment of a borderline population for future clinical studies on joints. Since health claims related to joint have been highly impacted by negative opinions, the opportunity may rekindle hope for market operators.

Find the Nutraingredients article here:
http://www.nutraingredients.com/Regulation/Consultants-divided-on-value-of-EU-joint-bone-health-claim-guidance

Thursday, May 31, 2012
Category : CONVICTIONS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags: , , , , , , , , , , , ,

EFSA published 2 scientific reports prepared by the University of East Anglia from Norwich (UK) in order to identify health outcomes upon which Dietary Reference Values could potentially be based for 6 minerals: magnesium, potassium, fluoride, chromium, manganese and molybdenum. The systematic searches and reviews were performed using databases Medline, EMBASE and the Cochrane Library Central. Here there are the selected inclusion/exclusion criteria:

– Data published in the English language from 1990 onwards
– Human studies conducted in generally healthy populations
– Studies which examined the relationship between micronutrient intake, status, and/or health
– Studies which were relevant to micronutrient intakes within the normal dietary/physiological range

Overall, the majority of studies identified were assessed as being at risk of bias. In addition, data were limited for the elderly, adolescents and children, with the exception of fluoride studies addressing tooth health. Thus, according to the results, the DRVs could not be established for these minerals. Relevant new data are therefore expected in order to conclude on this subject. Once again it is therefore surprising that, although these studies are biased and cannot be used to establish the VNRs, health claims are authorized for these minerals and can be used with only 15% of the RDAs!

References : Brown T., Mullee A., Collings R., Harvey L., Hooper L. and Fairweather-Tait S. Preparation of an evidence report identifying health outcomes upon which Dietary Reference Values could potentially be based for magnesium, potassium and fluoride. Scientific report submitted to EFSA. Accepted for publication on 14 May 2012.Mullee A., Brown T., Collings R., Harvey L., Hooper L. and Fairweather-Tait S. Preparation of an evidence report identifying health outcomes upon which Dietary Reference Values could potentially be based for chromium, manganese and molybdenum. Scientific report submitted to EFSA. Accepted for publication on 14 May 2012.

Thursday, May 3, 2012
Category : News, CLAIMS, CONVICTIONS, INGREDIENTS, INNOVATION, TRENDS | Author : experts | Comment : [:en]3 Comments[:fr]3 commentaires »
Tags: , , , , , , , , , , , , ,

You can discover:
-An analysis on herbal ingredients: the solution to innovate in health and nutrition
-Sports-related health claims: guidelines for EFSA application are coming
-The claims assessed
-Communication to health care professionals: interpretation of regulation by European Member States
– US dietary supplements are getting ready for Europe: Focus on Natural Products Expo West 2012
-Nutraveris is setting up its US office in New Jersey

-Food supplements and functional foods: appraisal of relations to consumers
-Focus on Satiereal®
-Scientific news

Come and get your copy free of charge and meet our experts in the SUPPLY SIDE Market place in New York from 8 to 10 may 2012 and at the VITAFOODS Europe in Geneva from 22 to 24 may 2012.
To receive a copy free of charge please contact us by mail!